Welcome to the UCSF Office of Research COVID-19 central clearinghouse for all UCSF COVID-19 related research, research publications, and funding opportunities.

UCSF researchers responded quickly and continue to address the challenges that the COVID-19 pandemic has brought forth. Their investigations range from fundamental virology, immunology, epidemiology, diagnostic development, drug target identification, therapeutic development and testing, development of animal models, medical interventions, socio-behavioral impacts, computational modelling, and clinical implementation.

Created by the UCSF Office of Research and research stakeholders at the emergence of the COVID-19 pandemic, this website is dedicated to encouraging and supporting COVID-19 and SARS-CoV-2 research collaboration on campus and within the global research community, as well as promoting targeted resources and awareness of funding opportunities aimed at COVID-19 and SARS-CoV-2. Our goal is to serve as both a single central resource for the UCSF research community to find all of the information they need to build connections, find funding, and generate new knowledge to fully understand COVID-19 and SARS-CoV-2, as well as an overarching view of the spectrum of scientific discovery currently in progress at UCSF in these two areas.

Members of the public are invited to learn about the range of our current research-in-progress and explore specific projects as well as opportunities to participate in clinical trials. Thank you for your interest in UCSF research.

UCSF researchers are encouraged to consider new and innovative cross-disciplinary collaborations. Researchers can take a deep dive into our work, finding detailed information on UCSF-based COVID-19 related research projects by topic, contact information for lead PIs, and funding opportunities. This information is available via MyAccess (see main menu Login link).

Funder Highlights

NIAID September 2024 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Fiscal Year (FY) 2026 Division of Microbiology and Infectious Diseases (DMID) Concepts

• Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes
• Rational Design of Vaccines Against Hepatitis C Virus
• In Vitro Assessments for Antimicrobial Activity
• Impact of Initial Influenza Exposure on Immunity in Infants
• Collaborative Influenza Vaccine Innovation Centers (CIVICs)
• Clinical Research Operations Core
• Notice of Special Interest (NOSI)—Advancing Research Needed to Develop a Universal Influenza Vaccine

​

UCSF COVID-19 related research funding information:

The Office of Sponsored Research provides up-to-date information on ongoing NIH COVID-19-related matters.  You can find these at https://osr.ucsf.edu/nih-updates and search on COVID.

[DUE FOR UPDATES... Please be patient] OSR also reports the following summary of COVID-19 related proposals and awards as of  03/12/2023:

• Total proposals: 952
• Total requested: 1,404,406,389
• Total awards: 432
• Total awarded: 423,391,644

* Note:  Award totals and amounts may not match other reporting sources due to differences in definition, inclusion criteria/dates, attributes, and reporting methodology. Above numbers reflect dollars for entire award period, not just the initial year.  

Want expert, up-to-date scientific or medical information on COVID-19?  Check out the highly valuable UCSF Division of HIV, Infectious Diseases & Global Medicine website and their archive of the COVID-19 DIGEST, a weekly digest prepared during 2020-2021 from the Cross-Campus Infectious Diseases COVID-19 Task Force.

California Department of Public Health [https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/Respiratory-Viruses/RespiratoryDashboard.aspx]

• Hospitalization data:
  • On April 30, 2024, the Federal mandate for COVID-19-associated and influenza-associated hospitalization data to be reported to CDC’s National Healthcare Safety Network (NHSN) expired. NHSN data on California hospitalizations for both COVID-19 and influenza will no longer be displayed on the CDPH dashboard.
  • Historical California COVID-19 and influenza hospitalization data are available on the  Open Data Portal​.
• ​Death data:
  • COVID-19
    • As of January 1, 2023, death data was sourced from the California Department of Public Health, California Comprehensive Death File (Dynamic), 2023–Present. Prior to January 1, 2023, death data was sourced from the COVID-19 case registry. The change in data source occurred in July 2023 and was applied retroactively to all 2023 data to provide a consistent source of death data for the year of 2023.

Quote of the Week